CorMedix
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $39,736 | $39,081 | $31,209 | $11,456 |
Gross Profit | 37,874 | 37,484 | 30,034 | 10,769 |
EBITDA | 20,519 | 20,815 | 13,646 | -2,652 |
EBIT | 20,356 | 20,653 | 13,474 | -2,766 |
Net Income | 19,827 | 20,643 | 13,464 | -2,776 |
Net Change In Cash | 39,736 | 39,081 | 31,209 | 11,456 |
Free Cash Flow | 29,967 | 19,726 | -5,624 | -13,659 |
Cash | 159,308 | 66,285 | 40,650 | 35,286 |
Basic Shares | 71,918 | 68,975 | 61,508 | 58,825 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43,472 | $0 | $65 | $190 |
Gross Profit | 40,281 | -205 | 61 | 41 |
EBITDA | -18,831 | -48,887 | -30,051 | -29,375 |
EBIT | -19,288 | -48,957 | -30,260 | -29,552 |
Net Income | -17,930 | -46,339 | -29,701 | -28,210 |
Net Change In Cash | 43,472 | 0 | 65 | 190 |
Cost of Revenue | 11,454 | |||
Free Cash Flow | -50,730 | -38,736 | -24,576 | -22,580 |
Cash | 40,650 | 43,642 | 43,374 | 53,551 |
Basic Shares | 58,871 | 50,902 | 40,274 | 37,666 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.28 |
2025-03-31 | $0.29 |
2024-12-31 | $0.22 |
2024-09-30 | -$0.05 |
